Brief: Cassava Sciences Made Decision To Enter Settlement With SEC

Filana Therapeutics

08/10/2024 13:28

Oct 8 (Reuters) - Cassava Sciences Inc  SAVA.O :
    * CASSAVA SCIENCES-  MADE DECISION TO ENTER SETTLEMENT WITH
SEC
    * CASSAVA SCIENCES INC - DO NOT ANTICIPATE DOJ WILL CHARGE
CO OR
SEEK RESOLUTION FROM CO
    * CASSAVA SCIENCES INC - WILL SEPARATE CEO AND BOARD CHAIR
ROLES
    * CASSAVA SCIENCES- AGREED TO SETTLE CHARGE OF 'NEGLIGENTLY
MAKING
INACCURATE DISCLOSURES' RELATED TO 2020 PHASE 2B CLINICAL STUDY

Source text for Eikon:  ID:n0001437749-24-030845 
Further company coverage:  SAVA.O 

 ((Reuters.Briefs@thomsonreuters.com;))